Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Granulocyte Colony-stimulating Factor (G-CSF) Mobilized”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Early research (Phase 1)Study completedNCT00400556
What this trial is testing

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Multiple MyelomaCutaneous Lymphoma
Peter MacCallum Cancer Centre, Australia 6
Not applicableStudy completedNCT01901458
What this trial is testing

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Who this might be right for
Healthy Allogeneic DonorsGranulocyte Colony-stimulating Factor (G-CSF) Mobilized
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Not applicableStudy completedNCT01362179
What this trial is testing

National Marrow Donor Program Long-Term Donor Follow-Up

Who this might be right for
Hematologic Neoplasms
Center for International Blood and Marrow Transplant Research 21,974
Testing effectiveness (Phase 2)Study completedNCT02078102
What this trial is testing

A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Sherif S. Farag 38
Testing effectiveness (Phase 2)Study completedNCT01329900
What this trial is testing

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00008268
What this trial is testing

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01097057
What this trial is testing

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

Who this might be right for
Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00117455
What this trial is testing

Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT01016795
What this trial is testing

Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma

Who this might be right for
Malignant Lymphoma
Aalborg University Hospital 32
Large-scale testing (Phase 3)UnknownNCT00394498
What this trial is testing

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

Who this might be right for
Myocardial Infarction
University of Ottawa 86
Large-scale testing (Phase 3)Study completedNCT01908621
What this trial is testing

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

Who this might be right for
Multiple Myeloma
Maria Sklodowska-Curie National Research Institute of Oncology 90
Testing effectiveness (Phase 2)Study completedNCT00082329
What this trial is testing

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 9
Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00208949
What this trial is testing

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF

Who this might be right for
Hematologic Diseases
Emory University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03246529
What this trial is testing

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
BioLineRx, Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00234169
What this trial is testing

Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Who this might be right for
Multiple MyelomaLymphoma
Peter MacCallum Cancer Centre, Australia 30
Not applicableLooking for participantsNCT07186179
What this trial is testing

Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)

Who this might be right for
Diamond Blackfan Anemia
Northwell Health 10
Post-approval studies (Phase 4)Looking for participantsNCT01553214
What this trial is testing

Improving White Blood Cell Collection From Healthy Donors

Who this might be right for
Allogeneic Granulocyte Donation
National Institutes of Health Clinical Center (CC) 1,000
Not applicableEnded earlyNCT01899326
What this trial is testing

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
DS (Durie/Salmon) Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
Albert Einstein College of Medicine 10
Load More Results